Umeå University's logo

umu.sePublications
Change search
Link to record
Permanent link

Direct link
Alternative names
Publications (10 of 170) Show all publications
Jonsson, P. & Stegmayr, B. G. (2025). Contamination of microbubbles of air may occur at all investigated measurement points during hemodialysis. International Journal of Artificial Organs
Open this publication in new window or tab >>Contamination of microbubbles of air may occur at all investigated measurement points during hemodialysis
2025 (English)In: International Journal of Artificial Organs, ISSN 0391-3988, E-ISSN 1724-6040Article in journal (Refereed) Epub ahead of print
Abstract [en]

Microbubbles (MBs) of air occur in the hemodialysis (HD) extracorporeal circuit and may enter the bloodlines of the patient. The aim of the present study was to investigate possible sites of contamination. Seventeen patients performed 20 HD (Baxter AK200S n = 5 and Artis n = 15) and 930 ultrasound measurements of MBs/min (Hatteland CMD10 device). Detection ranges were diameters between 2.5 and 50 µm. Hemodiafiltration with postdilution (HDF-post) was performed in 14 dialyses, predilution (HDF-pre) in 1 dialysis, and HD using hemocontrol (HDhc) in 5 dialyses. Measurement points were M1—after the blood access, M2—before the dialyzer, M3—after the dialyzer, and M4—after the venous chamber. At each point, 10 measures of MBs were performed. MB contamination of the blood was larger at all points when the access was an arteriovenous fistula compared to a central dialysis catheter (p < 0.001). MB levels with the AK200 versus the Artis were lower at M1, higher at M2 (p ⩽ 0.005), and were similar at M3 and M4. HDF-pre had fewer MBs than HDF-post, whereas HDhc had more MBs than HDF-post (p < 0.001). An increase of MBs was seen at M2 during an internal “Autotest.” No air alarms were induced during dialyses. MBs were detected in the extra corporeal circuit at all points investigated. The venous chambers used did not significantly reduce contamination. The detected MBs did not induce air alarms when the blood returned to the patient.

Place, publisher, year, edition, pages
Sage Publications, 2025
Keywords
adverse events, air contamination, hemodiafiltration, Hemodialysis, microbubbles
National Category
Urology Nephrology
Identifiers
urn:nbn:se:umu:diva-238695 (URN)10.1177/03913988251334953 (DOI)001481178700001 ()40320670 (PubMedID)2-s2.0-105004313296 (Scopus ID)
Available from: 2025-05-23 Created: 2025-05-23 Last updated: 2025-05-23
Lindberg, H., Knight, A., Hellbacher, E., Norling, O., Berglin, E., Stegmayr, B., . . . Dahlqvist, J. (2025). In-depth analysis of disease manifestations in antineutrophil cytoplasmic antibody–associated vasculitides identifies distinct clinical phenotypes. ACR Open Rheumatology, 7(3), Article ID e70009.
Open this publication in new window or tab >>In-depth analysis of disease manifestations in antineutrophil cytoplasmic antibody–associated vasculitides identifies distinct clinical phenotypes
Show others...
2025 (English)In: ACR Open Rheumatology, E-ISSN 2578-5745, Vol. 7, no 3, article id e70009Article in journal (Refereed) Published
Abstract [en]

Objective: The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides are heterogeneous disorders. The aim of this study was to identify and characterize subgroups of patients based on sex, ANCA, age at diagnosis, and organ involvement.

Methods: In total, 1,167 patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) were retrospectively recruited to the study. Data including cumulative involvement of 10 different organ systems, end-stage kidney disease (ESKD), sex, proteinase (PR) 3–ANCA, myeloperoxidase (MPO)-ANCA, age at diagnosis, disease duration, and relapse were obtained from medical records. Clinical variables were analyzed for associations with sex, age at diagnosis, and relapse using logistic regression analysis. Thirteen clinical variables were included in hierarchical cluster analyses using the Ward method.

Results: In patients with GPA, PR3-ANCA, renal and pulmonary involvement, and ESKD were significantly associated with male sex, whereas MPO-ANCA was associated with female sex. Patients with GPA who were younger than 32 years of age at diagnosis were significantly more often females and had more ear–nose–throat involvement than patients older than 32 years. In patients with MPA, female patients were significantly younger at diagnosis than male patients. Relapse was significantly associated with young age at diagnosis and pulmonary involvement in GPA and with musculoskeletal involvement in MPA. Hierarchical cluster analyses identified five and seven patient clusters among individuals with GPA and MPA, respectively. PR3-/MPO-ANCA defined the largest clusters, whereas heart, gastrointestinal, and central nervous system involvement were hallmarks for three clusters for both patients with GPA and MPA.

Conclusion: Sex, age at diagnosis, and specific organ involvements define clinically relevant subgroups among patients with ANCA-associated vasculitides.

Place, publisher, year, edition, pages
John Wiley & Sons, 2025
National Category
Rheumatology Autoimmunity and Inflammation
Identifiers
urn:nbn:se:umu:diva-236661 (URN)10.1002/acr2.70009 (DOI)001436607100001 ()40033657 (PubMedID)2-s2.0-86000238617 (Scopus ID)
Funder
Swedish Society of MedicineSwedish Society for Medical Research (SSMF)Swedish Rheumatism AssociationStiftelsen Konung Gustaf V:s 80-årsfondAgnes and Mac Rudberg FoundationThe Swedish Kidney Foundation
Available from: 2025-03-26 Created: 2025-03-26 Last updated: 2025-03-26Bibliographically approved
Stegmayr, B., Vrielink, H., Witt, V., Derfler, K., Deeren, D., Bojanic, I., . . . Newman, E. (2025). Update of data from the world apheresis association (WAA) registry. Transfusion and apheresis science, 64(3), Article ID 104132.
Open this publication in new window or tab >>Update of data from the world apheresis association (WAA) registry
Show others...
2025 (English)In: Transfusion and apheresis science, ISSN 1473-0502, E-ISSN 1878-1683, Vol. 64, no 3, article id 104132Article, review/survey (Refereed) Published
Abstract [en]

The WAA registry has been active since 2002. It allows bed side registration of safety and efficacy data. The data each center enters is accessible for its own use but also used for merged analysis. Most types of procedures are represented. Treatments of many severe diseases as well as the collection of autologous and donor cells for therapeutic use especially in oncologic diseases are recorded. Previous reports have shown a successive reduction in adverse events (AE) over the years. The aim of the present report is to update data of the risk for AE during the years from 2013 to Oct 2024. Contributions of 44 centers from 20 countries were analysed. Over these years, more than 169,000 apheresis procedures have been registered in more than 26,000 patients. During the study period the mean incidence of AE, merged for all types of procedures, was 1.6 /100 procedures for mild, 2.0/100 for moderate and 0.20/100 for severe AE, and reduced since 2013. Since 2002, death due to apheresis could not be excluded in one patient. There was an increased risk of hypotension during apheresis in patients with neurological diagnoses (ICD-10 chapter G) versus those with diseases of the musculoskeletal or connective tissue (ICD-10 chapter M) and vice versa for urticaria and tingling. In conclusion, the present data show the risk for various degrees of AE in apheresis procedures. Many patients suffer from severe illness and apheresis is often offered as a rescue therapy. Although the risk of death due to the apheresis procedure is extremely rare the concomitant severe disease itself poses a risk for severe events.

Place, publisher, year, edition, pages
Elsevier, 2025
Keywords
Adverse events, Apheresis, Fluid replacement, Risks
National Category
Hematology
Identifiers
urn:nbn:se:umu:diva-238603 (URN)10.1016/j.transci.2025.104132 (DOI)40328001 (PubMedID)2-s2.0-105003996809 (Scopus ID)
Available from: 2025-05-09 Created: 2025-05-09 Last updated: 2025-05-09Bibliographically approved
Nasic, S., Mölne, J., Eriksson, M., Stegmayr, B., Afghahi, H. & Peters, B. (2024). Changes in numbers of glomerular macrophages between two consecutive biopsies and the association with renal transplant graft survival. Clinical Transplantation, 38(7), Article ID e15384.
Open this publication in new window or tab >>Changes in numbers of glomerular macrophages between two consecutive biopsies and the association with renal transplant graft survival
Show others...
2024 (English)In: Clinical Transplantation, ISSN 0902-0063, E-ISSN 1399-0012, Vol. 38, no 7, article id e15384Article in journal (Refereed) Published
Abstract [en]

Background: Macrophages are involved in kidney transplants. The aim of the study was to investigate if changes exist in the levels of glomerular macrophage index (GMI) between two consecutive kidney transplant biopsies, and if so to determine their potential impact on graft survival.

Methods: Two consecutive biopsies were performed on the same renal graft in 623 patients. GMI was categorized into three GMI classes: ≤1.8 Low, 1.9–4.5 Medium, and ≥4.6 High. This division yielded nine possible switches between the first and second biopsies (Low-Low, Low-Medium, etc.). Cox-regressions were used and hazard ratios (HR) with 95% confidence interval (CI) are presented.

Results: The worst graft survival was observed in the High-High group, and the best graft survival was observed in the Low-Low and High-Low groups. Compared to the High-High group, a reduction of risk was observed in nearly all other decreasing groups (reductions between 65% and 80% of graft loss). After adjustment for covariates, the risk for graft-loss was lower in the Low-Low (HR = 0.24, CI 0.13–0.46), Low-Medium (HR = 0.25, CI 0.11–0.55), Medium-Low (HR = 0.29, CI 0.11–0.77), and the High-Low GMI (HR = 0.31, CI 0.10–0.98) groups compared to the High-High group as the reference.

Conclusions: GMI may change dynamically, and the latest finding is of most prognostic importance. GMI should be considered in all evaluations of biopsy findings since high or increasing GMI levels are associated with shorter graft survival. Future studies need to consider therapeutic strategies to lower or maintain a low GMI. A high GMI besides a vague histological finding should be considered as a warning sign requiring more frequent clinical follow up.

Place, publisher, year, edition, pages
John Wiley & Sons, 2024
Keywords
biopsy, graft survival, kidney (allograft) function/dysfunction
National Category
Clinical Medicine
Identifiers
urn:nbn:se:umu:diva-227885 (URN)10.1111/ctr.15384 (DOI)001263209300001 ()38967592 (PubMedID)2-s2.0-85197503734 (Scopus ID)
Funder
Region Västra Götaland
Available from: 2024-07-15 Created: 2024-07-15 Last updated: 2025-04-24Bibliographically approved
Stegmayr, B. G. & Lundberg, L. D. (2024). Hemodialysis patients have signs of a chronic thrombotic burden. BMC Nephrology, 25(1), Article ID 223.
Open this publication in new window or tab >>Hemodialysis patients have signs of a chronic thrombotic burden
2024 (English)In: BMC Nephrology, E-ISSN 1471-2369, Vol. 25, no 1, article id 223Article in journal (Refereed) Published
Abstract [en]

Background: Cardiovascular diseases are the dominant cause of morbidity in hemodialysis (HD) patients. Unless sufficient anticoagulation is used during HD, clotting may appear. The objective was to investigate if levels of fibrin degradation products (D-dimer) were increased before and during HD.

Methods: The combined observational study included 20 patients performing a total of 60 hemodialysis divided into three sessions of low-flux dialysis. None of the patients suffered from any clinically evident thromboembolic event before or during the study. Median bolus anticoagulation (mainly tinzaparin) doses were 84 Units/kg bow. Blood samples were drawn before HD (predialysis), and at 30min and 180min during HD with focus on analyzing D-dimer levels and its relation to interdialytic weight gain (IDWG) and speed of fluid elimination by HD (UF-rate).

Results: Predialysis, D-dimer levels (mean 0.767 ±0.821, min 0.136mg/L) were above the upper reference value in 95% of the sessions. D-dimer levels were lowered at 30min (p<0.001) and returned to predialysis levels at 180min. Predialysis D-dimer correlated with NT-pro-BNP, Troponin T, IDWG and UF-rate. Multiple regression analysis revealed that the D-dimer levels were significantly related to IDWG and the UF-rate.

Conclusions: D-dimer levels were elevated in a high proportion predialysis and during HD and related to the IDWG and the UF-rate. Awareness of D-dimer levels and future studies will help clarify if optimization of those variables, besides anticoagulation and biocompatibility measures, will eradicate the repeated subclinical thromboembolic events related to each HD; one reason that may explain organ damage and shortened life span of these patients.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2024
Keywords
D-dimer, Hemodialysis, Interdialytic weight gain, Thrombosis, Ultrafiltration
National Category
Clinical Medicine
Identifiers
urn:nbn:se:umu:diva-228008 (URN)10.1186/s12882-024-03654-3 (DOI)001271548800001 ()38997655 (PubMedID)2-s2.0-85198376336 (Scopus ID)
Available from: 2024-07-22 Created: 2024-07-22 Last updated: 2025-04-24Bibliographically approved
Kuklin, V., Sovershaev, M., Bjerner, J., Keith, P., Scott, L. K., Thomas, O. M., . . . Stegmayr, B. (2024). Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis. Critical Care, 28(1), Article ID 12.
Open this publication in new window or tab >>Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis
Show others...
2024 (English)In: Critical Care, ISSN 1364-8535, E-ISSN 1466-609X, Vol. 28, no 1, article id 12Article, review/survey (Refereed) Published
Abstract [en]

Introduction: The impact of therapeutic plasma exchange (TPE) on short-term mortality in adult patients with sepsis-induced organ dysfunction remains uncertain. The objective of the study is to assess the effect of adjunct TPE in this setting through a comprehensive literature review.

Methods: The National Library of Medicine’s Medline, Ovid (Embase), the Cochrane Library database and clinicaltrial.gov from January 01, 1966, until October 01, 2022, were searched for terms: therapeutic plasma exchange, plasmapheresis, sepsis, and septic shock. We reviewed, selected and extracted data from relevant randomized clinical trials (RCTs) and matched cohort studies (MCSs) comparing short-term mortality in critically ill adult septic patients treated with standard therapy versus those receiving adjunct TPE. Risk of bias was assessed in the RCTs using Cochrane Collaboration tool and in MCSs using ROBINS-I tool. Summary statistics, risk ratios (RRs), and confidence intervals (CIs) were calculated using random effects model.

Results: This systematic review included 937 adult critically ill septic patients from five RCTs (n = 367) and fifteen MCSs (n = 570). Of these total, 543 received treatment with TPE in addition to standard care. The meta-analysis includes all five RCTs and only six MCSs (n = 627). The adjunct TPE treatment (n = 300) showed a significant reduction in short-term mortality (RR 0.59, 95% CI 0.47–0.74, I2 3%) compared to standard therapy alone (n = 327). The systematic review of all 20 trials revealed that adding TPE to the standard therapy of critically ill septic patients resulted in faster clinical and/or laboratory recovery.

Conclusions: Our comprehensive and up-to-date review demonstrates that adjunct TPE may provide potential survival benefits when compared to standard care for critically ill adult patients with sepsis-induced organ dysfunction. While results of this meta-analysis are encouraging, large well-designed randomized trials are required to identify the optimal patient population and TPE procedure characteristics prior to widespread adoption into practice.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2024
National Category
Anesthesiology and Intensive Care General Practice
Identifiers
urn:nbn:se:umu:diva-219502 (URN)10.1186/s13054-023-04795-x (DOI)001136741700001 ()38178170 (PubMedID)2-s2.0-85181516433 (Scopus ID)
Available from: 2024-01-24 Created: 2024-01-24 Last updated: 2024-01-24Bibliographically approved
Goto, J., Ott, M. & Stegmayr, B. (2024). Myocardial markers are highly altered by higher rates of fluid removal during hemodialysis. Hemodialysis International, 28(1), 17-23
Open this publication in new window or tab >>Myocardial markers are highly altered by higher rates of fluid removal during hemodialysis
2024 (English)In: Hemodialysis International, ISSN 1492-7535, E-ISSN 1542-4758, Vol. 28, no 1, p. 17-23Article in journal (Refereed) Published
Abstract [en]

Introduction: Although hemodialysis is lifesaving in patients with kidney failure extensive interdialytic weight gain (IDWG) between dialyses worsens the prognosis. We recently showed a strong correlation between IDWG and predialytic values of cardiac markers. The aim of the present study was to evaluate if the cardiac markers N-terminal pro-B-type natriuretic peptide (proBNP) and troponin T were influenced by IDWG and speed of fluid removal (ultrafiltration-rate).

Methods: Twenty hemodialysis patients performed in total 60 hemodialysis (three each). Predialytic values of proBNP and troponin T and changes from predialysis to 180 min hemodialysis (180–0 min) were compared with the IDWG calculated in percent of body weight. The ultrafiltration-rate was adjusted (UF-rateadj) to IDWG: (100 × weight gain between dialysis [kg])/(estimated body dry weight [kg] × length of hemodialysis session [hours]).

Results: UF-rateadj correlated (Spearman) with (1) predialytic values of IDWG (r = 0.983, p < 0.001), proBNP (r = 0.443, p < 0.001), and troponin T (r = 0.296, p = 0.025); and (2) differences in proBNP180–0min (r = 0.572, p < 0.001) and troponin T180–0min (r = 0.400, p = 0.002). UF-ratesadj above a breakpoint of 0.60 caused more release of proBNP180–0min (p = 0.027). Remaining variables in multiple regression analysis with ProBNP180–0min as dependent factor were predialytic proBNP (p < 0.001) and the ultrafiltration-rate (p < 0.001).

Conclusion: Higher UF-rateadj during dialysis was correlated to increased levels of cardiac markers. Data support a UF-rateadj lower than 0.6 to limit such increase. Further studies may confirm if limited fluid intake and a lower UF-rateadj should be recommended to prevent cardiac injury during dialysis.

Place, publisher, year, edition, pages
John Wiley & Sons, 2024
Keywords
biocompatibility, embolies, heart, hemodialysis, interdialytic weight gain
National Category
Clinical Medicine
Identifiers
urn:nbn:se:umu:diva-215930 (URN)10.1111/hdi.13124 (DOI)001091396400001 ()37875435 (PubMedID)2-s2.0-85174612023 (Scopus ID)
Funder
Umeå University
Available from: 2023-11-02 Created: 2023-11-02 Last updated: 2025-02-18Bibliographically approved
Forsberg, U., Jonsson, P. & Stegmayr, B. (2024). The Emboless® venous chamber efficiently reduces air bubbles: a randomized study of chronichemodialysis patients. Clinical Kidney Journal, 17(11), Article ID sfae323.
Open this publication in new window or tab >>The Emboless® venous chamber efficiently reduces air bubbles: a randomized study of chronichemodialysis patients
2024 (English)In: Clinical Kidney Journal, ISSN 2048-8505, E-ISSN 2048-8513, Vol. 17, no 11, article id sfae323Article in journal (Refereed) Published
Abstract [en]

Background. When blood passes the extracorporeal circuit, air microbubbles (MBs) contaminate the blood. Some MBs will end up as microemboli in the lung, heart, and brain. MB exposure has no medical purpose and is considered to be bio-incompatible. Selecting venous chambers with a high removal rate of MBs is warranted to reduce the risks of air bio-incompatibility. The primary aim was to compare the Fresenius 5008 (F5008-VC) and the Emboless® (Emboless-VC) venous chambers regarding the elimination of MBs in the return bloodline during hemodialysis (HD).

Methods. Twenty patients underwent 80 sessions of cross-over HD using both the F5008-VC and the Emboless-VC randomized such that half started with the F5008-VC and half with the Emboless-VC. For 32 of the 80 sessions, measurements were also performed during hemodiafiltrations (HDF) after the initial HD. MBs were measured with an ultrasound device (within the size range of 20–500 μm) at the “inlet” and “outlet” bloodline of the venous chambers. The Wilcoxon pairwise test compared the percentage of MB elimination between venous chambers.

Results. During HD, the median reduction of MBs for the outlet was 39% with the F5008-VC and 76% with the Emboless-VC (P < .001). During HDF, the reduction was 28% with the F5008-VC and 70% with the Emboless-VC (P < .001).

Conclusion. Fewer MBs and subsequently fewer microemboli entered the bloodline of the patient using the Emboless-VC compared to the F5008-VC venous chamber during HD and during HDF. Venous chambers with a high removal rate of MBs will reduce the extent of air emboli.

Place, publisher, year, edition, pages
Oxford University Press, 2024
Keywords
bio-compatibility, cardiovascular, hemodiafiltration, hemodialysis, thrombosis
National Category
Clinical Medicine Cardiology and Cardiovascular Disease
Identifiers
urn:nbn:se:umu:diva-232588 (URN)10.1093/ckj/sfae323 (DOI)001360992100001 ()39574541 (PubMedID)2-s2.0-85210286352 (Scopus ID)
Funder
VinnovaRegion VästerbottenThe Swedish Kidney Foundation
Available from: 2024-12-09 Created: 2024-12-09 Last updated: 2025-02-18Bibliographically approved
Witt, V. & Stegmayr, B. (2024). The WAA-registry. Transfusion and apheresis science, Article ID 103889.
Open this publication in new window or tab >>The WAA-registry
2024 (English)In: Transfusion and apheresis science, ISSN 1473-0502, E-ISSN 1878-1683, article id 103889Article in journal, Editorial material (Other academic) In press
Place, publisher, year, edition, pages
Elsevier, 2024
National Category
Hematology
Identifiers
urn:nbn:se:umu:diva-221846 (URN)10.1016/j.transci.2024.103889 (DOI)38388335 (PubMedID)2-s2.0-85186074898 (Scopus ID)
Available from: 2024-03-12 Created: 2024-03-12 Last updated: 2024-03-12Bibliographically approved
Peters, B., Beige, J., Siwy, J., Rudnicki, M., Wendt, R., Ortiz, A., . . . Stegmayr, B. (2023). Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy. Nephrology, Dialysis and Transplantation, 38(12), 2826-2834
Open this publication in new window or tab >>Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy
Show others...
2023 (English)In: Nephrology, Dialysis and Transplantation, ISSN 0931-0509, E-ISSN 1460-2385, Vol. 38, no 12, p. 2826-2834Article in journal (Refereed) Published
Abstract [en]

Background: Immunoglobulin A nephropathy (IgAN) frequently leads to kidney failure. The urinary proteomics-based classifier IgAN237 may predict disease progression at the time of kidney biopsy. We studied whether IgAN237 also predicts progression later in the course of IgAN.

Methods: Urine from patients with biopsy-proven IgAN was analyzed using capillary electrophoresis-mass spectrometry at baseline (IgAN237-1, n = 103) and at follow-up (IgAN237-2, n = 89). Patients were categorized as "non-progressors" (IgAN237 ≤0.38) and "progressors" (IgAN237 >0.38). Estimated glomerular filtration rate (eGFR) and urinary albumin-creatinine ratio slopes were calculated.

Results: Median age at biopsy was 44 years, interval between biopsy and IgAN237-1 was 65 months and interval between IgAN237-1 and IgAN237-2 was 258 days (interquartile range 71-531). IgAN237-1 and IgAN237-2 values did not differ significantly and were correlated (rho = 0.44, P < .001). Twenty-eight percent and 26% of patients were progressors based on IgAN237-1 and IgAN237-2, respectively. IgAN237 inversely correlated with chronic eGFR slopes (rho = -0.278, P = .02 for score-1; rho = -0.409, P = .002 for score-2) and with ±180 days eGFR slopes (rho = -0.31, P = .009 and rho = -0.439, P = .001, respectively). The ±180 days eGFR slopes were worse for progressors than for non-progressors (median -5.98 versus -1.22 mL/min/1.73 m2 per year for IgAN237-1, P < .001; -3.02 vs 1.08 mL/min/1.73 m2 per year for IgAN237-2, P = .0047). In multiple regression analysis baseline progressor/non-progressor according to IgAN237 was an independent predictor of eGFR180days-slope (= .001).

Conclusion: The urinary IgAN237 classifier represents a risk stratification tool in IgAN also later in the course of the dynamic disease. It may guide patient management in an individualized manner.

Place, publisher, year, edition, pages
Oxford University Press, 2023
Keywords
biomarker, CKD, glomerulonephritis, IgA nephropathy, progression, urine proteomics
National Category
Clinical Medicine
Identifiers
urn:nbn:se:umu:diva-218129 (URN)10.1093/ndt/gfad125 (DOI)001023602500001 ()37349951 (PubMedID)2-s2.0-85178650918 (Scopus ID)
Funder
Swedish Research Council, 2018-05615European Commission
Available from: 2023-12-15 Created: 2023-12-15 Last updated: 2025-02-18Bibliographically approved
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0003-2694-7035

Search in DiVA

Show all publications